SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-12-037328
Filing Date
2012-06-29
Accepted
2012-06-29 16:14:39
Documents
1
Period of Report
2012-06-27

Document Format Files

Seq Description Document Type Size
1 form451559_20120629041403-.html 4  
1 form451559_20120629041403-.xml 4 3741
  Complete submission text file 0001144204-12-037328.txt   5194
Mailing Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421
Business Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Issuer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 667 MADISON AVE 17TH FLOOR NEW YORK NY 10021
Business Address
Biggar Stephen R (Reporting) CIK: 0001340380 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23155 | Film No.: 12936226